Tag Archives: biotech industry

Raising the Stakes in Biotech

JimGreenwood

Small biotech companies continue to struggle to obtain funding as capital markets remain tight. The S&P downgrade may create even tighter credit markets and raise the cost of available credit, for small and large companies. To the extent that the downgrade leads capital flows out of the U.S., that hurts biotech. Biotech’s contributions to the world are critically needed. Our industry holds great promise for curing and treating many prevalent diseases, such as Alzheimer’s, cancer, Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Public Opinion: What do voters think about biotechnology?

Graph

The majority of voters recognize the important work being conducted at biotech companies and place a high value on the industry’s contributions. After only a brief neutral description of the biotechnology industry, 87% of those polled have a favorable image of the biotech industry. More than three-quarters of Americans surveyed are convinced that biotech is working every day on curing diseases such as Alzheimer’s, cancer, diabetes and Parinson’s. Furthermore, they believe that these cures will Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Could 3 minutes reshape California’s biotech future?

Ron Leuty from BiotechSF writes: In just three minutes the other day, Maryland received more than 180 applications for its $8 million biotech tax credit program. The program, which rewards investors for putting cash in biotech startups, is one of many that states are offering to jumpstart or grow their life sciences communities.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

How we are advancing American innovation to cure disease and save lives

JimGreenwood

Mankind’s need to cure disease, combat hunger and discover new forms of energy has never been more urgent. Yet despite the extraordinary hope offered by biotechnology to solve these problems, government policies and the capital formation environment necessary to support these goals are insufficiently conducive to allowing us to meet these critical challenges. During our 2011 BIO International Convention, we unveiled a strategic initiative to speed scientific breakthroughs, develop cures and grow the bio-economy. The Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Docs at BIO: Steve Burrill’s State of the Biotechnology Industry Report 2011

Kevin Noonan from patent Patent Docs writes: The underlying theme of his message this year was that the predominant feature of the biotechnology environment is change, and rapid change. Such change provides challenges but in characteristic fashion Mr. Burrill … espoused the belief that change provides “extraordinary opportunities.” Patent Docs is part of our BIO Official Blogger Program.

Events  |  Leave a comment  |  Email This Post
Tags: , , ,